Antidepressant effects of a plant-derived flavonoid baicalein involving extracellular signal-regulated kinases cascade

Biological and Pharmaceutical Bulletin

Volumn 34, Issue 2, 2011, Pages 253-259

  Xiong, Zhe ^a   Jiang, Bo ^a   Wu, Peng Fei ^a   Tian, Jia ^a,c   Shi, Liang Liang ^a,c   Gu, Jun ^a   Hu, Zhuang Li ^a,b,c   Fu, Hui ^a,b,c   Wang, Fang ^a,b,c   Chen, Jian Guo ^a,b,c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Baicalein; Chronic unpredictable mild stress; Forced swimming test; Tail suspending test

Indexed keywords

BAICALEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; IMIPRAMINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG MECHANISM; ENZYME PHOSPHORYLATION; FORCED SWIMMING TEST; HIPPOCAMPUS; IMMOBILIZATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSION; DISEASE MODELS, ANIMAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVANONES; HIPPOCAMPUS; MALE; MICE; MICE, INBRED STRAINS; MOTOR ACTIVITY; PHOSPHORYLATION; PHYTOTHERAPY; PLANT EXTRACTS; PLANT ROOTS; RATS; RATS, SPRAGUE-DAWLEY; SCUTELLARIA BAICALENSIS; SWIMMING;

EID: 79551503904     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.34.253     Document Type: Article

References (37)

1. Reeves H., Batra S., May R. S., Zhang R., Dahl D. C., Li X., J. Clin. Psychiatry, 69, 1228-1236 (2008).
2. Böer U., Noll C., Cierny I., Krause D., Hiemke C., Knepel W., Eur. J. Pharmacol., 633, 33-38 (2010).
3. Kwon S., Lee B., Kim M., Lee H., Park H. J., Hahm D. H., Prog. Neuropsychopharmacol. Biol. Psychiatry, 34, 265-270 (2010).
4. Yi L. T., Zhang L., Ding A. W., Xu Q., Zhu Q., Kong L. D., Arch. Pharm. Res., 32, 1417-1423 (2009).
5. Drew M. R., Hen R., CNS Neurol. Disord. Drug Targets, 6, 205-218 (2007).
6. Yan H. C., Qu H. D., Sun L. R., Li S. J., Cao X., Fang Y. Y., Jie W., Bean J. C., Wu W. K., Zhu X. H., Gao T. M., Int. J. Neuropsychopharmacol., 13, 623-633 (2010).
7. Massa S. M., Yang T., Xie Y., Shi J., Bilgen M., Joyce J. N., Nehama D., Rajadas J., Longo F. M., J. Clin. Invest., 120, 1774-1785 (2010).
8. Wang R., Li Y. H., Xu Y., Li Y. B., Wu H. L., Guo H., Zhang J. Z., Zhang J. J., Pan X. Y., Li X. J., Prog. Neuropsychopharmacol. Biol. Psychiatry, 34, 147-153 (2010).
9. Musazzi L., Mallei A., Tardito D., Gruber S. H., El Khoury A., Racagni G., Mathé A. A., Popoli M., J. Psychiatr. Res., 44, 511-520 (2010).
10. Yung L. Y., Tso P. H., Wu E. H., Yu J. C., Ip N. Y., Wong Y. H., Cell Signal., 20, 1538-1544 (2008).
11. Creson T. K., Yuan P., Manji H. K., Chen G., J. Mol. Neurosci., 37, 123-134 (2009).
12. Qi X., Lin W., Li J., Li H., Wang W., Wang D., Sun M., Neurobiol. Dis., 31, 278-285 (2008).
13. Liu C., Wu J., Gu J., Xiong Z., Wang F., Wang J., Wang W., Chen J., Pharmacol. Biochem. Behav., 86, 423-430 (2007).
14. Xiong Z., Liu C., Wang F., Li C., Wang W., Wang J., Chen J., Biol. Pharm. Bull., 29, 1880-1885 (2006).
15. Lin F., Xin Y., Wang J., Ma L., Liu J., Liu C., Long L., Wang F., Jin Y., Zhou J., Chen J., Eur. J. Pharmacol., 570, 43-49 (2007).
16. Maher P., Arch. Biochem. Biophys., 476, 139-144 (2008).
17. Lu Y. H., Du C. B., Liu J. W., Hong W., Wei D. Z., Am. J. Chin. Med., 32, 397-405 (2004).
18. Borrelli F., Izzo A. A., AAPS J., 11, 710-727 (2009).
19. Kawabata K., Kawai Y., Terao J., J. Nutr. Biochem., 21, 374-380 (2009).
20. Tsai T. H., Liu S. C., Tsai P. L., Ho L. K., Shum A. Y., Chen C. F., Br. J. Pharm., 137, 1314-1320 (2002).
21. Liu C., Wu J., Xu K., Cai F., Gu J., Ma L., Chen J., J. Neurochem., 112, 1500-1512 (2010).
22. Park S. J., Kim D. H., Kim J. M., Shin C. Y., Cheong J. H., Ko K. H., Ryu J. H., Brain Res., 1355, 141-150 (2010).
23. Steru L., Chermat R., Thierry B., Simon P., Psychopharmacology, 85, 367-370 (1985).
24. Lucki I., Behav. Pharmacol., 8, 523-532 (1997).
25. Lu X. Y., Kim C. S., Frazer A., Zhang W., Proc. Natl. Acad. Sci. U.S.A., 103, 1593-1608 (2006).
26. Porsolt R. D., Le Pichon M., Jalfre M., Nature (London), 266, 730-742 (1977).
27. Li S., Wang C., Wang M., Li W., Matsumoto K., Tang Y., Life Sci., 80, 1373-1381 (2007).
28. Ferreira A., Hansen S., Nielsen M., Archer T., Minor B. G., Behav. Neurosci., 103, 193-201 (1989).
29. Wang T., Gu J., Wu P. F., Wang F., Xiong Z., Yang Y. J., Wu W. N., Dong L. D., Chen J., Free Radic. Biol. Med., 47, 229-240 (2009).
30. Willner P., Neuropsychobiology, 52, 90-110 (2005).
31. Hellweg R., Ziegenhorn A., Heuser I., Deuschle M., Pharmacopsychiatry, 41, 66-71 (2008).
32. Boldrini M., Underwood M. D., Hen R., Rosoklija G. B., Dwork A. J., John Mann J., Arango V., Neuropsychopharmacology, 34, 2376-2389 (2009).
33. Lee J. S., Jang D. J., Lee N., Ko H. G., Kim H., Kim Y. S., Kim B., Son J., Kim S. H., Chung H., Son H., J. Neurosci., 29, 8493-8505 (2009).
34. Chen M. J., Nguyen T. V., Pike C. J., Russo-Neustadt A. A., Cell Signal., 19, 114-128 (2007).
35. Overstreet D. H., Fredericks K., Knapp D., Breese G., McMichael J., Pharmacol. Biochem. Behav., 94, 553-560 (2010).
36. Tabakman R., Jiang H., Shahar I., Arien-Zakay H., Levine R. A., Lazarovici P., Ann. N.Y. Acad. Sci., 1053, 84-96 (2005).
37. Angelucci F., Mathé A. A., Aloe L., Prog. Brain Res., 146, 151-165 (2004).